Pharma Stocks
-
Wall Street Thinks This Biotech Stock Can Soar 45%. Here’s Why Analysts Are Right.
Shares of Alnylam Pharmaceuticals (ALNY +3.69%) have dropped 24% so far this year (through June 30). The biotech company is…
Read More » -
Wall Street Thinks This Biotech Stock Can Soar 45%. Here’s Why Analysts Are Right.
Key Points The company has six marketed therapies and several others in late-stage clinical trials. Alnylam has a unique drug…
Read More » -
Neuren Pharmaceuticals (ASX:NEU) Wins CHMP Backing, Is The Upside Already Priced In?
Neuren Pharmaceuticals (ASX:NEU) is back in focus after the European Medicines Agency’s CHMP issued a positive opinion on its Rett…
Read More » -
Telix Pharmaceuticals (ASX:TLX) in Focus After Positive U.S. Regulatory Update
Highlights • Telix Pharmaceuticals shares rose 0.41% to AUD 17.09 during the morning session on 2 July 2026 following a…
Read More » -
How Teva’s Ecopipam NDA for Pediatric Tourette Syndrome (TEVA) Has Changed Its Investment Story
In June 2026, Teva Pharmaceutical Industries announced it had submitted a New Drug Application to the FDA for ecopipam, a…
Read More » -
Recordati strengthens its pharma profile as a European specialty player
Recordati S.p.A. (ISIN IT0003828271) is an Italy-based specialty pharmaceutical company with a long history in prescription medicines, rare disease treatments…
Read More » -
Pharma Stock Gains as Healthcare Investors Watch Recovery Catalysts
Highlights • Mayne Pharma (MYX) has reported heightened investor interest as the healthcare sector watches for recovery catalysts. •…
Read More » -
AI Drug Discovery Stocks Retail Investors Are Watching After Claude Science
Anthropic’s launch of Claude Science has thrown fresh attention on stocks that sit at the intersection of artificial intelligence and…
Read More » -
ACADIA Pharmaceuticals (ACAD) In Focus As Europe Backs Daybue And Undervalued View Holds
Regulatory milestone in Europe puts ACADIA Pharmaceuticals stock in focus The latest move in ACADIA Pharmaceuticals (ACAD) stock was driven…
Read More » -
Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results?
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off…
Read More »